What is Global Point-Of-Care Or Rapid Diagnostics Market?
The Global Point-Of-Care or Rapid Diagnostics Market is a rapidly growing sector in the healthcare industry. This market focuses on the production and distribution of medical diagnostic tests that can be performed immediately at the patient's location, without the need for a specialized laboratory. These tests are designed to be quick, easy to use, and accurate, providing immediate results that can help healthcare providers make informed decisions about patient care. The global market for these tests was valued at a substantial US$ 25670 million in 2023, and it's projected to almost double in value by 2030, reaching an impressive US$ 48500 million. This represents a compound annual growth rate (CAGR) of 9.4% during the forecast period from 2024 to 2030.
Intensive Care, Covid-19 Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Others in the Global Point-Of-Care Or Rapid Diagnostics Market:
The Global Point-Of-Care or Rapid Diagnostics Market is divided into several segments based on the type of tests available. These include Intensive Care, Covid-19 Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, among others. Intensive Care is the largest segment, accounting for over 19% of the market. These tests are crucial in critical care settings, where quick and accurate results can mean the difference between life and death. Covid-19 Testing has also become a significant part of the market due to the ongoing pandemic. Infectious Diseases Testing, Cardiac Markers Testing, and Coagulation Testing are also important segments, providing essential diagnostic tools for a wide range of medical conditions.
Hospital, Clinic, Independent Laboratories, Others in the Global Point-Of-Care Or Rapid Diagnostics Market:
The Global Point-Of-Care or Rapid Diagnostics Market products are used in various healthcare settings. Hospitals are the largest users of these tests, as they often need to make quick decisions about patient care. Clinics also make use of these tests, particularly in areas where access to a full-scale laboratory may be limited. Independent Laboratories are another major user of point-of-care tests, as they can provide quick results for patients who visit for routine check-ups or specific health concerns. Other users include home care settings and emergency medical services, where rapid diagnostics can provide immediate information about a patient's condition.
Global Point-Of-Care Or Rapid Diagnostics Market Outlook:
Looking at the market outlook for the Global Point-Of-Care or Rapid Diagnostics Market, it's clear that this sector is set for significant growth. In 2023, the market was valued at US$ 25670 million, and it's expected to reach a staggering US$ 48500 million by 2030. This represents a compound annual growth rate (CAGR) of 9.4% during the forecast period from 2024 to 2030. The market is dominated by the top 5 manufacturers, who hold over 74% of the market share. In terms of products, Intensive Care is the largest segment, accounting for over 19% of the market.
| Report Metric | Details |
| Report Name | Point-Of-Care Or Rapid Diagnostics Market |
| Accounted market size in 2023 | US$ 25670 million |
| Forecasted market size in 2030 | US$ 48500 million |
| CAGR | 9.4% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, BioMerieux, Nova Biomedical, Thermo Fisher Scientific, Quidel, A. Menarini Diagnostics, Becton Dickinson, Biosurfit, Astrego Diagnostics, Werfen, Abionic, Palex Medical/Bülhmann, Horiba Medical, RAL, Vircell, Monlab, Binding Site |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
